Hengehold Capital Management LLC Has $229,000 Stock Holdings in Teleflex Incorporated (NYSE:TFX)

Hengehold Capital Management LLC boosted its position in shares of Teleflex Incorporated (NYSE:TFX) by 7.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,289 shares of the medical technology company’s stock after acquiring an additional 88 shares during the period. Hengehold Capital Management LLC’s holdings in Teleflex were worth $229,000 at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. Simplify Asset Management Inc. bought a new stake in Teleflex in the third quarter valued at about $4,800,000. JPMorgan Chase & Co. boosted its holdings in Teleflex by 14.3% during the third quarter. JPMorgan Chase & Co. now owns 155,158 shares of the medical technology company’s stock valued at $38,374,000 after purchasing an additional 19,466 shares in the last quarter. Northwestern Mutual Wealth Management Co. grew its stake in shares of Teleflex by 19.8% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 484 shares of the medical technology company’s stock valued at $102,000 after purchasing an additional 80 shares during the period. LGT Capital Partners LTD. raised its holdings in shares of Teleflex by 4.2% in the 3rd quarter. LGT Capital Partners LTD. now owns 231,685 shares of the medical technology company’s stock worth $57,300,000 after buying an additional 9,411 shares in the last quarter. Finally, Allspring Global Investments Holdings LLC lifted its position in shares of Teleflex by 41.5% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 24,301 shares of the medical technology company’s stock worth $6,010,000 after buying an additional 7,132 shares during the period. Institutional investors and hedge funds own 95.62% of the company’s stock.

Teleflex Trading Up 0.1 %

Shares of NYSE TFX opened at $180.95 on Friday. Teleflex Incorporated has a 1-year low of $171.69 and a 1-year high of $256.85. The company has a 50-day moving average of $183.07 and a two-hundred day moving average of $214.58. The company has a market cap of $8.40 billion, a PE ratio of 35.97, a P/E/G ratio of 1.79 and a beta of 1.16. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37.

Teleflex (NYSE:TFX) last posted its quarterly earnings data on Thursday, October 31st. The medical technology company reported $3.49 earnings per share for the quarter, topping the consensus estimate of $3.38 by $0.11. The firm had revenue of $764.40 million during the quarter, compared to analysts’ expectations of $768.68 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. Teleflex’s revenue was up 2.4% on a year-over-year basis. During the same quarter in the previous year, the company posted $3.64 EPS. As a group, equities analysts expect that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, December 16th. Investors of record on Friday, November 15th were given a $0.34 dividend. The ex-dividend date was Friday, November 15th. This represents a $1.36 dividend on an annualized basis and a yield of 0.75%. Teleflex’s payout ratio is 27.04%.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on TFX. Royal Bank of Canada dropped their price objective on Teleflex from $275.00 to $245.00 and set an “outperform” rating for the company in a research note on Friday, November 1st. Truist Financial dropped their target price on shares of Teleflex from $227.00 to $200.00 and set a “hold” rating for the company in a research report on Wednesday, December 18th. Needham & Company LLC restated a “hold” rating on shares of Teleflex in a research report on Monday, December 16th. Mizuho dropped their price objective on shares of Teleflex from $275.00 to $250.00 and set a “neutral” rating for the company in a report on Friday, November 1st. Finally, StockNews.com raised Teleflex from a “hold” rating to a “buy” rating in a report on Thursday, November 28th. Three investment analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $252.50.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.